Back
Verrica Pharmaceuticals Stock Price Chart

Market's down 10% YTD Buffet's Berkshire up 13%
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
VRCA
Verrica Pharmaceuticals
Last Price:
$0.49
Seasonality Move:
-11.93%
7 Day Trial
ALL ACCESS PASS
$
7

Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Verrica Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.5 | Sell |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.59 | Sell |
200-day SMA: | 2.08 | Sell |
8-day EMA: | 0.5 | Sell |
20-day EMA: | 0.51 | Sell |
50-day EMA: | 0.59 | Sell |
200-day EMA: | 1.93 | Sell |
Verrica Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 46.67 | Sell |
Chaikin Money Flow: | 374599 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.43 - 0.59) | Sell |
Bollinger Bands (100): | (0.51 - 0.89) | Sell |
Verrica Pharmaceuticals Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
-
Verrica Pharmaceuticals share price is 0.49 while VRCA 8-day simple moving average is 0.50, which is a Sell signal.
-
The stock price of VRCA is 0.49 while Verrica Pharmaceuticals 20-day SMA is 0.49, which makes it a Buy.
-
Verrica Pharmaceuticals 50-day simple moving average is 0.59 while VRCA share price is 0.49, making it a Sell technically.
-
VRCA stock price is 0.49 and Verrica Pharmaceuticals 200-day simple moving average is 2.08, creating a Sell signal.
VRCA Technical Analysis vs Fundamental Analysis
Sell
20
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a SellThe current Verrica Pharmaceuticals [VRCA] share price is $0.49. The Score for VRCA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
45M
Price in USD:
0.49
Share Volume:
374.6K
Verrica Pharmaceuticals 52-Week Range
52-Week High:
11.41
52-Week Low:
0.38
Sell
20
Verrica Pharmaceuticals (VRCA)
is a Sell
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?The Verrica Pharmaceuticals stock price is 0.49 USD today.
-
Will VRCA stock go up or go down?Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Verrica Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
-
Verrica Pharmaceuticals share price is 0.49 while VRCA 8-day exponential moving average is 0.50, which is a Sell signal.
-
The stock price of VRCA is 0.49 while Verrica Pharmaceuticals 20-day EMA is 0.51, which makes it a Sell.
-
Verrica Pharmaceuticals 50-day exponential moving average is 0.59 while VRCA share price is 0.49, making it a Sell technically.
-
VRCA stock price is 0.49 and Verrica Pharmaceuticals 200-day simple moving average is 1.93, creating a Sell signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.12 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
-
VRCA Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Verrica Pharmaceuticals is a Sell
-
Verrica Pharmaceuticals Relative Strength Index (RSI) is 46.67, which suggest Verrica Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Verrica Pharmaceuticals is (0.43 - 0.59), which suggest Verrica Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Verrica Pharmaceuticals is (0.51 - 0.89), which suggest Verrica Pharmaceuticals is a Sell
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.